Essex Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.18M Buy
184,375
+1,186
+0.6% +$31.6K 0.29% 76
2025
Q4
$4.56M Sell
183,189
-3,095
-2% -$78K 0.26% 82
2025
Q3
$4.75M Sell
186,284
-42,088
-18% -$1.04M 0.28% 77
2025
Q2
$5.54M Buy
228,372
+29,086
+15% +$678K 0.36% 62
2025
Q1
$5.05M Sell
199,286
-31,049
-13% -$812K 0.36% 62
2024
Q4
$6.11M Buy
230,335
+18,947
+9% +$514K 0.43% 50
2024
Q3
$6.1M Sell
211,388
-84,335
-29% -$2.46M 0.44% 52
2024
Q2
$8.5M Buy
295,723
+36,361
+14% +$1M 0.63% 32
2024
Q1
$7.2M Sell
259,362
-11,853
-4% -$329K 0.66% 32
2023
Q4
$7.81M Sell
271,215
-6,792
-2% -$205K 0.81% 26
2023
Q3
$9.22M Buy
278,007
+27,887
+11% +$986K 1.07% 18
2023
Q2
$9.17M Sell
250,120
-5,782
-2% -$225K 1.04% 19
2023
Q1
$10.4M Sell
255,902
-3,537
-1% -$153K 1.1% 16
2022
Q4
$13.3M Buy
259,439
+530
+0.2% +$25.4K 1.41% 14
2022
Q3
$11.3M Buy
258,909
+3,820
+1% +$186K 1.35% 14
2022
Q2
$13.4M Sell
255,089
-816
-0.3% -$41.6K 1.49% 10
2022
Q1
$13.2M Buy
255,905
+2,646
+1% +$137K 1.27% 13
2021
Q4
$15M Buy
253,259
+4,885
+2% +$242K 1.48% 10
2021
Q3
$10.7M Buy
248,374
+78,065
+46% +$3.46M 1.22% 13
2021
Q2
$6.17M Hold
170,309
0.89% 18
2021
Q1
$6.17M Sell
170,309
-452
-0.3% -$16K 1.11% 16
2020
Q4
$6.29M Sell
170,761
-3,137
-2% -$115K 1.24% 13
2020
Q3
$6.05M Buy
173,898
+17,020
+11% +$597K 1.49% 12
2020
Q2
$4.87M Buy
156,878
+38,853
+33% +$1.32M 1.5% 11
2020
Q1
$3.65M Sell
118,025
-1,412
-1% -$48.1K 1.3% 14
2019
Q4
$4.44M Sell
119,437
-2,348
-2% -$83.6K 1.22% 15
2019
Q3
$4.15M Sell
121,785
-144,624
-54% -$5.26M 1.34% 16
2019
Q2
$10.9M Buy
266,409
+2,519
+1% +$100K 3.23% 4
2019
Q1
$10.6M Sell
263,890
-17,619
-6% -$706K 3.21% 4
2018
Q4
$11.7M Sell
281,509
-43,555
-13% -$1.81M 3.57% 2
2018
Q3
$13.6M Sell
325,064
-23,912
-7% -$921K 2.99% 2
2018
Q2
$12M Buy
348,976
+3,424
+1% +$117K 2.89% 2
2018
Q1
$11.6M Sell
345,552
-7,579
-2% -$261K 2.28% 3
2017
Q4
$12.1M Sell
353,131
-8,272
-2% -$282K 2.88% 4
2017
Q3
$12.2M Buy
361,403
+14,371
+4% +$462K 3.01% 4
2017
Q2
$11.1M Buy
347,032
+193
+0.1% +$6.09K 2.33% 5
2017
Q1
$11.3M Sell
346,839
-40,697
-11% -$1.28M 2.59% 5
2016
Q4
$11.9M Buy
387,536
+18,118
+5% +$553K 2.56% 5
2016
Q3
$11.9M Sell
369,418
-239
-0.1% -$7.99K 2.82% 3
2016
Q2
$12.3M Sell
369,657
-5,893
-2% -$188K 2.99% 3
2016
Q1
$10.6M Sell
375,550
-5,020
-1% -$143K 2.62% 5
2015
Q4
$11.7M Buy
380,570
+129,888
+52% +$4.09M 2.8% 3
2015
Q3
$7.47M Buy
250,682
+19,083
+8% +$612K 1.94% 5
2015
Q2
$7.37M Sell
231,599
-7,789
-3% -$254K 1.9% 6
2015
Q1
$7.9M Sell
239,388
-28,772
-11% -$915K 2.03% 6
2014
Q4
$7.92M Buy
268,160
+5,669
+2% +$163K 2.06% 7
2014
Q3
$7.36M Sell
262,491
-20,063
-7% -$563K 2.2% 7
2014
Q2
$7.96M Buy
282,554
+791
+0.3% +$22.5K 2.38% 4
2014
Q1
$8.59M Sell
281,763
-1,211
-0.4% -$36.1K 2.8% 4
2013
Q4
$8.22M Buy
282,974
+1,935
+0.7% +$56.3K 2.78% 4
2013
Q3
$7.66K Sell
281,039
-10,235
-4% -$278K 2.41% 6
2013
Q2
$7.74M Buy
+291,274
New +$8.05M 2.71% 6

Other funds holding PFE

Essex Financial Services's PFE Position: Q1 2026 in Review

Essex Financial Services increased its Pfizer (PFE) stake by 0.65% in Q1 2026, buying an estimated $31.6K and bringing the position to 184,375 shares worth $5.18M. The position accounts for 0.29% of the portfolio, ranked #76.

Essex Financial Services first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $15M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Essex Financial Services held 184,375 shares of Pfizer worth $5.18M as of Q1 2026.
  • Essex Financial Services bought 1,186 Pfizer shares in Q1 2026, an estimated $31.6K.
  • Pfizer made up 0.29% of Essex Financial Services's portfolio in Q1 2026, its #76 holding.
  • Essex Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Essex Financial Services's Pfizer position peaked at $15M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.